Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction

Author(s):  
2020 ◽  
Vol 17 (10) ◽  
pp. 1385-1392
Author(s):  
Abhishek Suwal ◽  
Ji-long Hao ◽  
Dan-dan Zhou ◽  
Xiu-fen Liu ◽  
Raja Suwal ◽  
...  

2019 ◽  
Vol 103 (10) ◽  
pp. 1475-1480 ◽  
Author(s):  
Marc Labetoulle ◽  
Tristan Bourcier ◽  
Serge Doan

Background/aimsDry eye disease (DED) is categorised by pathophysiology as aqueous deficient dry eye (ADDE), evaporative dry eye (EDE) or mixed. Treatment should be tailored to DED pathophysiology, but this is challenging to determine. This Delphi consultation aimed to categorise and weight signs and symptoms to help identify the evaporative or aqueous deficient DED origin.MethodsA panel of French DED experts created an initial list of 77 DED signs and symptoms. In a Delphi consultation, experts categorised items by DED pathophysiology. Likert scoring was used to indicate whether items were strongly or moderately indicative of ADDE or EDE. Items could also be judged non-applicable to DED, with the opportunity to suggest alternative diagnoses.ResultsExperts attributed 19 items (of which 11 were strongly indicative) to a pathophysiology of EDE and 12 items (of which four were strongly indicative) to ADDE. Items scored strongly indicative with agreement >90% for EDE were previous chalazia, rosacea/rhinophyma, telangiectasias of eyelid margin and thick non-expressible meibomian gland secretions, and for ADDE were Sjögren syndrome or associated disease, and Schirmer <5 mm after 5 min (without anaesthesia). Seventeen items indicated neither pathophysiology and 18 items were found to be suggestive of alternative diagnoses.ConclusionsThis Delphi consultation categorised signs and symptoms, using an innovative weighting system to identify DED pathophysiology. An algorithm integrating the weighting of each sign and symptom of an individual patient would be valuable to help general ophthalmologists to classify the DED subtype and tailor treatment to DED underlying mechanism.


2016 ◽  
Vol 100 (3) ◽  
pp. 300-306 ◽  
Author(s):  
Christophe Baudouin ◽  
Elisabeth M Messmer ◽  
Pasquale Aragona ◽  
Gerd Geerling ◽  
Yonca A Akova ◽  
...  

2017 ◽  
Vol 23 (3) ◽  
pp. S297 ◽  
Author(s):  
Melina V. Rodrigues ◽  
Marilia M.T. Ferrer ◽  
Eliana C.M. Miranda ◽  
Marcos Paulo Colella ◽  
Francisco J.P. Aranha ◽  
...  

Cornea ◽  
2017 ◽  
Vol 36 (2) ◽  
pp. 189-195 ◽  
Author(s):  
Kang Won Lee ◽  
Jung Yong Kim ◽  
Hee Seung Chin ◽  
Kyoung Yul Seo ◽  
Tae-im Kim ◽  
...  

2021 ◽  
Vol 3 (3) ◽  
pp. 1-3
Author(s):  
Jose Salgado Borges ◽  
C. Vergés ◽  
J. Lima ◽  
March de Ribot F

Intense pulsed light (IPL) are medical-esthetical procedures that emit light at a wavelength of 500 – 1200 nm, interacting with epidermal and dermal tissues. IPL is a relatively new treatment of growing popularity thanks to its versatility and efficacy, mainly in dermatology and recently also in ophthalmology. These devices are used to treat dry eye disease, meibomian gland dysfunction, rosacea, and periocular lesions with outstanding results.


Sign in / Sign up

Export Citation Format

Share Document